Actionable news
0
All posts from Actionable news
Actionable news in LGND: Ligand Pharmaceuticals Incorporated,

Ligand Pharmaceuticals Inc.

Average Recommendation: Overweight Average Target Price: 136.20
Number of Ratings: 5 Current Quarters Estimate: 0.40
FY Report Date: 12 / 2016 Current Year's Estimate: 3.43
Last Quarter's Earnings: 0.97 Median PE on CY...

More